Overview

* Alignment Healthcare ( ALHC ) Q3 revenue grows 43.5% yr/yr, beating analyst expectations

* Company raises full-year outlook across all key metrics

Outlook

* Alignment Healthcare ( ALHC ) sees full-year revenue outlook to $3.931 bln - $3.946 bln

* Company expects Q4 revenue between $995 mln and $1.010 bln

* Alignment Healthcare ( ALHC ) forecasts full-year adjusted EBITDA of $90 mln to $98 mln

Result Drivers

* MEMBERSHIP GROWTH - Health plan membership increased by 25.9% yr/yr, contributing to revenue growth

* HIGH PLAN RATINGS - 100% of members in plans rated 4 stars or higher for second consecutive year

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $993.70 $981.35

Revenue mln mln (11

Analysts

)

Q3 EPS $0.02

Q3 Net $3.72

Income mln

Q3 $32.43

Adjusted mln

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the managed healthcare peer group is "buy"

* Wall Street's median 12-month price target for Alignment Healthcare Inc ( ALHC ) is $20.00, about 8.9% above its October 29 closing price of $18.21

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)